Chemical Compound

N-{1-[2-(Morpholin-4-yl)ethyl]-1H-1,3-benzimidazol-2-yl}-3-nitrobenzamide

CAS Registry Number 509093-47-4
N-{1-[2-(Morpholin-4-yl)ethyl]-1H-1,3-benzimidazol-2-yl}-3-nitrobenzamide 结构式
Primary record

N-{1-[2-(Morpholin-4-yl)ethyl]-1H-1,3-benzimidazol-2-yl}-3-nitrobenzamide

库存
743 克
纯度
99.4 %
CAS
509093-47-4

化合物标识与属性

CAS
509093-47-4
PubChem CID
11983295
SMILES
C1COCCN1CCN2C3=CC=CC=C3N=C2NC(=O)C4=CC(=CC=C4)[N+](=O)[O-]
Canonical SMILES
O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1

名称与同义词

  • IRAK-1-4 Inhibitor I
  • IRAK-1/4 Inhibitor
  • IRAK-1/4 Inhibitor I
  • 509093-47-4
  • IRAK-inh
  • IRAK1/4 Inhibitor I
  • IRAK-1-4InhibitorI
  • IRAK-1-4 Inhibitor
  • IRAK1/4 inhibitor 1
  • IRAK-1/4 Inhibitor?
  • RefChem:148685
  • D0I2FZ
  • CHEMBL379787
  • Interleukin-1 Receptor-Associated-Kinase-1/4 Inhibitor
  • MLS006010636
  • MFCD09752602
  • C20H21N5O4
  • GTPL5990
  • orb1305457
  • SCHEMBL3600534
  • SCHEMBL29363239
  • CTK8E9833
  • DTXSID50475143
  • QTCFYQHZJIIHBS-UHFFFAOYSA-N
  • GLXC-07524
  • HMS3229G05
  • HMS3263A20
  • HMS3744A07
  • BCP16164
  • EX-A1254
  • JVA09347
  • KS-00001D4X
  • Tox21_501049
  • 3747AH
  • BDBM50184706
  • IN1449
  • s6598
  • ZINC16052821
  • N-[1-(2-morpholin-4-ylethyl)benzimidazol-2-yl]-3-nitrobenzamide
  • AKOS026750497
  • CCG-206760
  • CS-0704
  • LP01049
  • SDCCGSBI-0086683.P002
  • SDCCGSBI-0086683.P005
  • CID11983295
  • N-(1-(2-morpholinoethyl)-1H-benzo[d]imidazol-2-yl)-3-nitrobenzamide
  • NCGC00186035-01
  • NCGC00186035-02
  • NCGC00186035-03
  • NCGC00186035-04
  • NCGC00186035-10
  • NCGC00261734-01
  • BS-17437
  • DA-64492
  • HY-13329
  • SMR001456469
  • SY347032
  • RT-013346
  • A3505
  • Interleukin-1 Receptor-Associated-Kinase-1/4
  • J3.545.430F
  • N-(2-Morpholinylethyl)-2-(3-nitrobenzoylamido)-benzimidazole
  • A11462
  • F17398
  • W-5402
  • A871423
  • IRAK-1/4 Inhibitor I, >=98% (HPLC), solid
  • N-[1-(2-morpholinoethyl)benzimidazol-2-yl]-3-nitro-benzamide
  • N-[1-[2-(4-morpholinyl)ethyl]-1H-benzimidazol-2-yl]-3-nitrobenzamide
  • Q27078097
  • 1-(2-(4-Morpholinyl)ethyl)-2-(3-nitrobenzoylamino)benzimidazole
  • Benzamide, N-[1-[2-(4-morpholinyl)ethyl]-1H-benzimidazol-2-yl]-3-nitro-
  • N-{1-[2-(morpholin-4-yl)ethyl]-1H-1,3-benzodiazol-2-yl}-3-nitrobenzamide
  • B2693-302024
  • N-[1-(2-Morpholinoethyl)-2-benzimidazolyl]-3-nitrobenzamide
  • 1-(2-(4-morpholinyl) ethyl)-2-(3-nitrobenzoylamino) benzimidazole
  • N-[1-(2-morpholin-4-ylethyl)benzoimidazol-2-yl]-3-nitro-benzamide
  • 1-[2-(4-Morpholinyl)ethyl]-2-(3-nitrobenzoylamino)-1H-benzoimidazole
  • 3-nitro-N-(1-(2-morpholin-4-yl-ethyl)-1H-benzoimidazol-2-yl)-benzamide
  • N-{1-[2-(morpholin-4-yl)ethyl]-1,3-benzodiazol-2-yl}-3-nitrobenzamide
  • N-(1-(2-(morpholin-4-yl)ethyl)-1H-1,3-benzodiazol-2-yl)-3-nitrobenzamide
  • N-{1-[2-(Morpholin-4-yl)ethyl]-1H-1,3-benzimidazol-2-yl}-3-nitrobenzamide